Having genetic factors can raise a person’s risk of uterine cancer. Currently, there is no screening test, but some signs and symptoms may indicate a person has it. Cancer that starts in the uterus, ...

When several people in a family develop gastrointestinal (GI) cancers, genetic factors may be responsible. Many of these factors are not currently known. Hereditary cancer syndromes are unusual, but ...

Most people have at least one extended family member who has had cancer. But does that put you at a higher risk for developing cancer? Baylor College of Medicine genetic counselor Tanya Eble explains ...

Hereditary cancer syndromes are disorders that increase your risk of certain cancers due to mutations in one or more genes inherited from your parents. Genetic testing can help you determine your risk ...

If a relative is diagnosed with cancer, a relative may be able to test to see if they have a higher risk of developing that same cancer. If a relative is diagnosed with cancer, a relative may be able ...

Huntsman Cancer Institute genetic counselor Sam Beck, MS, CGC, answers common questions people ask about pancreatic cancer and the genetic testing associated with it. People at an increased risk for ...

As a part of its “Speaking Out” video series, CURE spoke with Stacy Lloyd on behalf of the VHL Alliance, about discussing hereditary cancer with family members and how a diagnosis can lead to earlier ...

MSK understands the cancer care needs of people who have hereditary breast cancer. Our experts choose treatments based on types of breast cancer caused by genetic mutations. Hereditary breast cancer ...

Bone cancer is a rare type of cancer that occurs in the skeletal system. It typically occurs due to changes in genes that affect how cells grow. While people typically acquire these gene changes ...

I believe I have hereditary cancer, especially after my daughter was approved to receive genetic testing for breast cancer. I don’t have the BRCA gene mutation. Neither does my daughter. She and I are ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...